Previous close | 1.3650 |
Open | 1.3490 |
Bid | 1.2200 x 3100 |
Ask | 1.2800 x 2900 |
Day's range | 1.2500 - 1.4200 |
52-week range | 0.8800 - 5.5300 |
Volume | |
Avg. volume | 9,896,740 |
Market cap | 246.71M |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Significant control over bluebird bio by retail investors implies that the general public has more power...
A simultaneous pair of approvals from the U.S. Food and Drug Administration gives investors new factors to consider.
Bluebird (BLUE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.